Novel Autologous Cell Therapy in Ischemic Limb Disease Through Growth Factor Secretion by Cultured Adipose Tissue–Derived Stromal Cells

Objective—The delivery of autologous progenitor cells into ischemic tissue of patients is emerging as a novel therapeutic option. Here, we report the potential impact of cultured adipose tissue–derived cells (ADSC) on angiogenic cell therapy. Method and Results—ADSC were isolated from C57Bl/6 mouse inguinal adipose tissue and showed high expression of ScaI and CD44, but not c-kit, Lin, CD34, CD45, CD11b, and CD31, compatible with that of mesenchymal stem cells from bone marrow. In coculture conditions with ADSC and human aortic endothelial cells (ECs) under treatment with growth factors, ADSC significantly increased EC viability, migration and tube formation mainly through secretion of vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF). At 4 weeks after transplantation of ADSC into the ischemic mouse hindlimb, the angiogenic scores were improved in the ADSC-treated group, which were evaluated with blood flow by laser Doppler imaging (LDI) and capillary density by immunostaining with anti-CD31 antibody. However, injected ADSC did not correspond to CD31, von Willebrand factor, and &agr;-smooth muscle actin-positive cells in ischemic tissue. Conclusion—These adipose tissue–derived cells demonstrated potential as angiogenic cell therapy for ischemic disease, which appears to be mainly achieved by their ability to secrete angiogenic growth factors.

[1]  L. Sjöström,et al.  Isolation and characterization of cells from rat adipose tissue developing into adipocytes. , 1978, Journal of lipid research.

[2]  E. Dejana,et al.  Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. , 1996, Blood.

[3]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[4]  M. Shibuya,et al.  Interleukin-1βUpregulates Cardiac Expression of Vascular Endothelial Growth Factor and its Receptor KDR/flk-1 via Activation of Protein Tyrosine Kinases , 1999 .

[5]  Y. Mori,et al.  Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases. , 1999, Journal of molecular and cellular cardiology.

[6]  J. Isner,et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Jun Yamashita,et al.  Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors , 2000, Nature.

[8]  Y. Taniyama,et al.  Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease , 2001, Gene Therapy.

[9]  H. Nishimatsu,et al.  Endothelial nitric oxide synthase is essential for the HMG‐CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  J. Isner,et al.  Therapeutic angiogenesis for ischemic cardiovascular disease. , 2001, Journal of molecular and cellular cardiology.

[11]  J. Isner,et al.  Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia , 2001, Circulation.

[12]  H. Lorenz,et al.  Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.

[13]  Y. Taniyama,et al.  Mitogenic and Antiapoptotic Actions of Hepatocyte Growth Factor Through ERK, STAT3, and Akt in Endothelial Cells , 2001, Hypertension.

[14]  J. Isner,et al.  Therapeutic Angiogenesis for Coronary Artery Disease , 2002, Annals of Internal Medicine.

[15]  B. Lowell,et al.  Adipose tissue mass can be regulated through the vasculature , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  I. Weissman,et al.  Little Evidence for Developmental Plasticity of Adult Hematopoietic Stem Cells , 2002, Science.

[17]  K. Hirata,et al.  Involvement of Endothelial Nitric Oxide in Sphingosine-1-Phosphate–Induced Angiogenesis , 2001 .

[18]  K. Shimada,et al.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial , 2002, The Lancet.

[19]  T. Murohara,et al.  Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. , 2002, The Journal of clinical investigation.

[20]  R. Jain,et al.  Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis , 2003, Circulation research.

[21]  P. Carmeliet.  Angiogenesis in health and disease , 2003, Nature Medicine.

[22]  A. Katz,et al.  Mesenchymal stem cells from rat visceral fat exhibit multipotential differentiation in vitro. , 2003, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[23]  R. Considine,et al.  Obesity is associated with increased levels of circulating hepatocyte growth factor. , 2003, Journal of the American College of Cardiology.

[24]  Shahin Rafii,et al.  Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration , 2003, Nature Medicine.

[25]  B. Larson,et al.  Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. , 2004, Blood.

[26]  Keith L. March,et al.  Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells , 2004, Circulation.

[27]  M. Migita,et al.  Osteogenic and chondrogenic differentiation by adipose-derived stem cells harvested from GFP transgenic mice. , 2004, Biochemical and biophysical research communications.

[28]  M. Aoki,et al.  Safety Evaluation of Clinical Gene Therapy Using Hepatocyte Growth Factor to Treat Peripheral Arterial Disease , 2004, Hypertension.

[29]  B. Lévy,et al.  Plasticity of Human Adipose Lineage Cells Toward Endothelial Cells: Physiological and Therapeutic Perspectives , 2004, Circulation.

[30]  K. Alitalo,et al.  Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. , 2004, Blood.

[31]  W. Schaper,et al.  Bone marrow-Derived Cells Do Not Incorporate Into the Adult Growing Vasculature , 2004, Circulation research.

[32]  M. Migita,et al.  Chondrogenic and osteogenic differentiation of adipose-derived stem cells isolated from GFP transgenic mice. , 2004, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[33]  R Busse,et al.  Improvement of Postnatal Neovascularization by Human Adipose Tissue–Derived Stem Cells , 2004, Circulation.